Abdelrhman Abu-Moawad Profile
Abdelrhman Abu-Moawad

@AbumoawadA

Followers
136
Following
207
Media
13
Statuses
76

Vascular Medicine Fellow @the_BMC IM Resident @UMKC Post Doc Research Fellow @MayoClinic

Joined January 2022
Don't wanna be here? Send us removal request.
@AbumoawadA
Abdelrhman Abu-Moawad
2 months
Thank you SVM!
@SVM_tweets
Society for Vascular Medicine | SVM
2 months
0
0
6
@LeiliBehrooz
Leili Behrooz
4 months
Join us for the upcoming webinar “Navigating Career Pathways in Vascular Medicine” hosted by American College of Cardiology @ACCinTouch in collaboration with Society of Vascular Medicine @SVM_tweets August 4th, 7 pm EST. Learn more & Register here: https://t.co/YIfzuln4KX
0
5
10
@AbumoawadA
Abdelrhman Abu-Moawad
10 months
Excited to share our latest expert commentary @ACCinTouch on the role of rivaroxaban beyond 6 weeks in isolated distal DVT! Evidence suggests extending therapy can reduce recurrent VTE risk over 2 years without increasing major bleeding. #DVT @YSCastroMD https://t.co/mJz1R3uodP
Tweet card summary image
acc.org
3
1
7
@AbumoawadA
Abdelrhman Abu-Moawad
1 year
Lots of lessons to be learned from BEST-CLI and BASIL-2. One ☝️ important lesson is that mortality in patients with CLTI is high regardless of the revascularization strategy, so optimizing risk factors is crucial to improve overall prognosis. @BatoolAbuhalim1 @LeiliBehrooz
@ACCinTouch
American College of Cardiology
2 years
📍 An integrated, multidisciplinary approach is imperative to manage complex CLTI cases. Read an expert analysis on lessons learned from the BEST-CLI & BASIL-2 trials: https://t.co/RY8tE4Eza2 #CathLab
0
1
2
@ACCinTouch
American College of Cardiology
2 years
📍 An integrated, multidisciplinary approach is imperative to manage complex CLTI cases. Read an expert analysis on lessons learned from the BEST-CLI & BASIL-2 trials: https://t.co/RY8tE4Eza2 #CathLab
Tweet card summary image
acc.org
1
5
10
@PVDCouncil
AHA Peripheral Vascular Disease Council
2 years
Congratulations to the writing committee. Much needed update
@AHAScience
AHA Science
2 years
1/ Published today: The updated evidence-based recommendations for managing Lower Extremity PAD, originally outlined in the 2016 Guideline, now incorporate the latest research findings to assist clinicians. ✍🏽:@heatherlgornik 📖: @CircAHA
1
10
25
@AbumoawadA
Abdelrhman Abu-Moawad
2 years
Check out our new paper exploring the optimal medical management in patients with symptomatic PAD in Annals-of-vascular-surgery. @avsgjournal @LeiliBehrooz @dafirstwalross #Improve_PAD_Care Grateful for the mentorship, Thank you Dr. Robert T. Eberhardt https://t.co/WadRrmPSf9
0
0
4
@BatoolAbuhalim1
Batool Abuhalimeh
2 years
🔬📚 Check out our expert analysis on lessons learned from the groundbreaking BEST-CLI and BASIL-2 trials and how this impacts the future of vascular care. @AbumoawadA @LeiliBehrooz @CarlosMenaYale @YSCastroMD @ACCinTouch @VMJ_SVM https://t.co/cWlni2xPvd
Tweet card summary image
acc.org
1
4
16
@AndrewJSauer
Andrew J Sauer MD
2 years
Do you "wedge" the PA catheter in the CICU because you don't trust the surrogate PA diastolic? Compelling safety reasons to avoid doing this. A new study in @JCardFail validating the use of PA diastolic for most patients with left-sided predominant CS. https://t.co/wbkM7Obf2h
5
20
87
@KhaledBeydoun
Khaled Beydoun
2 years
Watch this.  Emily Callahan is a nurse with Doctors Without Borders. She shares her experience being in Gaza for 26 days.  I’m genuinely surprised @CNN aired her testimony.
70
1K
2K
@MusaSharkawiMD
Musa A. Sharkawi
2 years
Anything to say #MedTwitter? This isn’t worthy of outrage or even just empathy?
@yanisvaroufakis
Yanis Varoufakis
2 years
Dr Hamam Allouh, a specialist in Nephrology, was killed along with his family by an Israeli airstrike on their home. When last asked why he doesn’t evacuate he replied: "Who will treat the patients? I didn't study medicine for years to think about my life and leave the patients."
39
293
791
@MSF
MSF International
2 years
🔴BREAKING: Israel has given Al Awda Hospital just two hours to evacuate. Our staff are still treating patients. We unequivocally condemn this action, the continued indiscriminate bloodshed and attacks on health care in Gaza. We are trying to protect our staff and patients.
2K
33K
77K
@AbumoawadA
Abdelrhman Abu-Moawad
2 years
Excited that our expert analysis related to anticoagulants in patients with Antiphospholipid Syndromes has been chosen as an “Editor’s Pick”, and it will be one of the three images cycling across the top of the Latest in Cardiology page. @CarlosMenaYale Dr.Regan @ACCinTouch
1
1
8
@GBarnesMD
Geoff Barnes
2 years
It’s all about enoxaparin!! (or dalteparin, if you’re in Canada, right @LanaCastellucci and @DebSiegal ?)
@RosovskyRachel
Rachel Rosovsky
2 years
Dr. Cameron shares data that demonstrates PERT decrease PE mortality. Reach out to us to start your PERT ⁦@PERTConsortium#PERT2023@2Scottish
1
5
12
@AbumoawadA
Abdelrhman Abu-Moawad
2 years
Learning about the updated screening guidelines for Aortic Aneurysmwith Dr. @BatoolAbuhalim1 #SVM023
0
2
11
@AbumoawadA
Abdelrhman Abu-Moawad
2 years
#SVM2023 with Dr. @mcbunte learning about options for No Option CLTI. With Transcatheter Arterialization of Veins.
0
0
4
@SVM_tweets
Society for Vascular Medicine | SVM
2 years
0
3
7
@BatoolAbuhalim1
Batool Abuhalimeh
2 years
POCUS/Echcardiogram session happening now. Join us to learn more on how to utilize the use of ultrasound in your practice! @SVM_tweets @AmmarSaati @sthomas013s @PulkitChaudhury #SVM23
1
3
17
@AbumoawadA
Abdelrhman Abu-Moawad
2 years
@SVM_tweets having fun at SVM with @stanhenkin Thank you @Angiologist for making #SVM2023 such fun!!
0
1
4
@SVM_tweets
Society for Vascular Medicine | SVM
2 years
1
4
23